Tagala, Baby Girl -.
HRN: 27-15-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
MUPIROCIN 2%, 15G (TUBE)
05/29/2025
06/05/2025
TOPICAL
Pea-sized
BID
Skin Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes